A pipeline to extract drug-adverse event pairs from multiple data sources

被引:44
|
作者
Yeleswarapu, SriJyothsna [1 ]
Rao, Aditya [1 ]
Joseph, Thomas [1 ]
Saipradeep, Vangala Govindakrishnan [1 ]
Srinivasan, Rajgopal [1 ]
机构
[1] Tata Consultancy Serv Ltd, TCS Innovat Labs, Hyderabad 500081, Andhra Pradesh, India
关键词
Pharmacovigilance; NLP; Text mining; Social media; Adverse event; Biomedical literature; Unstructured text; BCPNN; ETHICAL-ISSUES; INTERNET; HEALTH; PHARMACOVIGILANCE; CORPUS;
D O I
10.1186/1472-6947-14-13
中图分类号
R-058 [];
学科分类号
摘要
Background: Pharmacovigilance aims to uncover and understand harmful side-effects of drugs, termed adverse events (AEs). Although the current process of pharmacovigilance is very systematic, the increasing amount of information available in specialized health-related websites as well as the exponential growth in medical literature presents a unique opportunity to supplement traditional adverse event gathering mechanisms with new-age ones. Method: We present a semi-automated pipeline to extract associations between drugs and side effects from traditional structured adverse event databases, enhanced by potential drug-adverse event pairs mined from user-comments from health-related websites and MEDLINE abstracts. The pipeline was tested using a set of 12 drugs representative of two previous studies of adverse event extraction from health-related websites and MEDLINE abstracts. Results: Testing the pipeline shows that mining non-traditional sources helps substantiate the adverse event databases. The non-traditional sources not only contain the known AEs, but also suggest some unreported AEs for drugs which can then be analyzed further. Conclusion: A semi-automated pipeline to extract the AE pairs from adverse event databases as well as potential AE pairs from non-traditional sources such as text from MEDLINE abstracts and user-comments from health-related websites is presented.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] A pipeline to extract drug-adverse event pairs from multiple data sources
    SriJyothsna Yeleswarapu
    Aditya Rao
    Thomas Joseph
    Vangala Govindakrishnan Saipradeep
    Rajgopal Srinivasan
    BMC Medical Informatics and Decision Making, 14
  • [2] Use of Exposure Data to Establish Causality in Drug-Adverse Event Relationships: An Example with Desvenlafaxine
    Rodriguez-Lopez, Andrea
    Mejia-Abril, Gina
    Zubiaur, Pablo
    Calleja, Sofia
    Roman, Manuel
    Abad-Santos, Francisco
    Ochoa, Dolores
    PHARMACEUTICALS, 2024, 17 (01)
  • [3] BAYESIAN-APPROACH TO ASSESSMENT OF THE DRUG-ADVERSE EVENT CAUSAL RELATIONSHIP
    AURICHE, M
    THERAPIE, 1985, 40 (05): : 301 - 306
  • [4] Drug-Event Pairs as Indicators for the Detection of Adverse Drug Reactions during Hospitalization in Routinely Collected Electronic Data Sources
    Wermund, Anna Maria
    Haerdtlein, Annette
    Fehrmann, Wolfgang
    Weglage, Clara
    Dreischulte, Tobias
    Jaehde, Ulrich
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2025,
  • [5] The impact of electronic medical records data sources on an adverse drug event quality measure
    Kahn, Michael G.
    Banade, Dalksha
    JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2010, 17 (02) : 185 - 191
  • [6] A Comparison Study of Algorithms to Detect Drug-Adverse Event Associations: Frequentist, Bayesian, and Machine-Learning Approaches
    Pham, Minh
    Cheng, Feng
    Ramachandran, Kandethody
    DRUG SAFETY, 2019, 42 (06) : 743 - 750
  • [7] Standardizing Drug Adverse Event Reporting Data
    Wang, Liwei
    Jiang, Guoqian
    Li, Dingcheng
    Liu, Hongfang
    MEDINFO 2013: PROCEEDINGS OF THE 14TH WORLD CONGRESS ON MEDICAL AND HEALTH INFORMATICS, PTS 1 AND 2, 2013, 192 : 1101 - 1101
  • [8] Standardizing adverse drug event reporting data
    Liwei Wang
    Guoqian Jiang
    Dingcheng Li
    Hongfang Liu
    Journal of Biomedical Semantics, 5
  • [9] Standardizing adverse drug event reporting data
    Wang, Liwei
    Jiang, Guoqian
    Li, Dingcheng
    Liu, Hongfang
    JOURNAL OF BIOMEDICAL SEMANTICS, 2014, 5
  • [10] Multiple sclerosis as an adverse drug reaction: clues from the FDA Adverse Event Reporting System
    Antonazzo, Ippazio Cosimo
    Raschi, Emanuel
    Forcesi, Emanuele
    Riise, Trond
    Bjornevik, Kjetil
    Baldin, Elisa
    De Ponti, Fabrizio
    Poluzzi, Elisabetta
    EXPERT OPINION ON DRUG SAFETY, 2018, 17 (09) : 869 - 874